Ets-2 is induced by oxidative stress and sensitizes cells to H2O2-induced apoptosis: Implications for Down's syndrome

Biochemical and Biophysical Research Communications

Volumn 287, Issue 4, 2001, Pages 1003-1008

  Sanij, E ^a   Hatzistavrou, T ^a   Hertzog, P ^a   Kola, I ^a   Wolvetang, E J ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME; GLUTATHIONE PEROXIDASE 1; HYDROGEN PEROXIDE; MESSENGER RNA; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR ETS 2; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL STRAIN 3T3; CHROMOSOME 21; CONTROLLED STUDY; DISEASE ASSOCIATION; DOSE TIME EFFECT RELATION; DOWN SYNDROME; FIBROBLAST; GENE DOSAGE; GENE OVEREXPRESSION; HUMAN; MOUSE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; SENSITIZATION; TRANSCRIPTION REGULATION;

EID: 0035812834     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2001.5680     Document Type: Article

References (29)

1. Etude des chromosome somatiques de neufs enfants mongoliens
2. Clinical aspects of Down's syndrome from infancy to adulthood
3. Simple minded mice from "in vivo" libraries
4. Animal models in the study of the biological function of genes on human chromosome 21 and their role in the pathophysiology of Down syndrome
5. Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro
6. 16)65Dn mouse, a murine model for human Down's syndrome
7. Diminished glutathione levels cause spontaneous and mitochondria-mediated cell death in neurons from trisomy 16 mice: A model of Down's syndrome
8. Mental modelling
9. Elevated expression of Ets2 or distinct portions of Ets2 can reverse Ras-mediated cellular transformation
10. Down's syndrome-like skeletal abnormalities in Ets-2 transgenic mice
11. c-ets-2 proto-oncogene has mitogenic and oncogenic activity
12. Rapid phosphorylation of Ets-2 accompanies mitogen activated protein kinase activation and the induction of heparin-binding epidermal growth factor gene expression by oncogeneic Raf-1
13. Persistent activation of mitogen-activated protein kinases p42 and p44 and ets-2 phosphorylation in response to colony-stimulating factor 1/c-fms signaling
14. Oxidative stress and neural dysfunction in Down syndrome
15. Superoxide dismutases
16. Mice with a homozygous null mutation to the most abundant glutathionine peroxidase GPX-1 show increased susceptibility to the oxidative stress-inducing agents paraquat and hydrogen peroxide
17. pEF-BOS, a powerful mammalian expression vector
18. Identification and characterization of a novel Ets-2-related nuclear complex implicated in the activation of the human interleukin-12 p40 gene promoter
19. The pathway to signal achievement
20. Transcriptional control by protein phosphorylation: Signal transmission from the cell surface to the nucleus
21. Lippolysaccharide induction of THP-1 cells activate binding of c-jun, ets and egr-1 to the tissue factor promoter
22. Ets-1 and Ets-2 in p53 regulation: Spatial separation of ETS binding sites (EBS) modulate protein: DNA interaction
23. Apoptosis-associated proteins p53 and APO-1/Fas (CD95) in brains of adult patients with Down syndrome
24. Molecular abnormalities of the brain in Down syndrome: Relevance to Alzheimer's neurodegeneration
25. Neuronal cell death in Down's syndrome
26. 2 by microdialysis following global forebrain ischemia and reperfusion in the rat: Correlation with the cytotoxic potential of H2O2 in vitro
27. 2 and tumor necrosis factor-α activate intercellular adhesion molecule 1(ICAM-1) gene transcription through distinct cis-regulatory elements within the ICAM-1 promoter
28. Combinatorial interactions between AP-1 and ets domain proteins contribute to the developmental regulation of the macrophage scavenger receptor gene